Table 5 Complications, mortality, and time spent on home NPPV among the studied patients for 12-month duration (n = 48)
Complications | Chronic respiratory failure on home NPPV | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total | Overlap syndrome (COPD and OSAS) (n = 15) | OHS (n = 14) | COPD (n = 6) | RTD (n = 9) | NMDs (n = 4) | ||||||||
No | % | No | % | No | % | No | % | No | % | ||||
No | 6 (12.5%) | 2 | 13.3 | 2 | 14.3 | 0 | 0.0 | 2 | 22.2 | 0 | 0.0 | ||
Yes | 42 (87.5%) | 13 | 86.7 | 12 | 85.7 | 6 | 100.0 | 7 | 77.8 | 4 | 100.0 | ||
Aerophagia | 14 (29.2%) | 5 | 33.3 | 4 | 28.6 | 1 | 16.7 | 2 | 22.2 | 2 | 50.0 | ||
Rhinitis | 11 (22.9%) | 3 | 20.0 | 3 | 21.4 | 1 | 16.7 | 2 | 22.2 | 2 | 50.0 | ||
Conjuctivitis | 6 (12.5%) | 0 | 0.0 | 2 | 14.3 | 2 | 33.3 | 1 | 11.1 | 1 | 25.0 | ||
Skin ulcer | 19 (39.6%) | 5 | 33.3 | 6 | 42.9 | 2 | 33.3 | 4 | 44.4 | 2 | 50.0 | ||
Air leak | 10 (20.8%) | 3 | 20.0 | 3 | 21.4 | 2 | 33.3 | 2 | 22.2 | 0 | 0.0 | ||
Claustrophobia | 4 (8.3%) | 1 | 6.7 | 1 | 7.1 | 1 | 16.7 | 1 | 11.1 | 0 | 0.0 | ||
Mortality | |||||||||||||
No | 45 (93.7%) | 14 | 93.3 | 13 | 92.9 | 6 | 100.0 | 9 | 100.0 | 3 | 75.0 | ||
Yes | 3 (6.3%) | 1 | 6.7 | 1 | 7.1 | 0 | 0 | 0 | 0 | 1 | 25 | χ2 = 3.195 | MCp = 0.598 |
Time spent on NIV(Mean±SD) | 5.93 ± 1.33 h | 6.14 ± 1.46 h | 5.67 ± 1.51 h | 6.11 ± 1.27 h | 5.75 ± 2.06 h | ||||||||